In the dynamic world of pharmaceutical development, the purity and availability of key intermediates are paramount. One such compound making significant contributions is 4-(Methylsulfonyl)phenylacetic Acid (CAS No.: 90536-66-6). This sophisticated chemical serves as a crucial building block, particularly in the synthesis of important active pharmaceutical ingredients (APIs). For researchers and procurement managers seeking high-quality raw materials, understanding the role and sourcing of this intermediate is vital.

The primary significance of 4-(Methylsulfonyl)phenylacetic Acid lies in its indispensability for the production of Etoricoxib. Etoricoxib is a selective COX-2 inhibitor widely prescribed for conditions such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. The efficient and cost-effective synthesis of Etoricoxib relies heavily on the consistent supply of high-purity 4-(Methylsulfonyl)phenylacetic Acid. When sourcing this compound, professionals often look for manufacturers in China known for their robust quality control and competitive pricing.

Beyond its application in Etoricoxib synthesis, 4-(Methylsulfonyl)phenylacetic Acid also finds use in the development of other biologically active molecules. Its unique sulfonyl group and phenylacetic acid structure make it a versatile intermediate for creating novel anti-inflammatory and analgesic agents, as well as compounds with antioxidant properties. This broad applicability underscores its value in a wide range of research and development projects within the pharmaceutical sector.

For procurement professionals, identifying a reliable supplier is key. When considering where to buy 4-(Methylsulfonyl)phenylacetic Acid, factors such as assay (purity), packaging, and supply chain stability are crucial. Manufacturers offering products with a purity of ≥96.0%, alongside transparent documentation and flexible packaging options, are highly sought after. The ability to procure this intermediate at a competitive price from a trusted manufacturer in China can significantly impact project timelines and budgets.

In conclusion, 4-(Methylsulfonyl)phenylacetic Acid is far more than just a chemical compound; it's a gateway to innovation in the pharmaceutical industry. Its role in enabling the production of essential medicines highlights the importance of its reliable sourcing. For businesses looking to secure this vital intermediate, engaging with experienced manufacturers who prioritize quality and efficiency is the strategic path forward.